Overview

Continuous Double Ovarian Stimulation.

Status:
Recruiting

Trial end date:
2023-05-30

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy of the weekly use of corifollitropin alfa in double ovarian stimulation process and to compare it to the conventional protocol with daily medication administration.

Phase:

Phase 4

Details

Lead Sponsor:

Instituto Bernabeu

Treatments:

Follicle Stimulating Hormone
Hormones